Transforming growth factor-β1 increases the expression of lectin-like oxidized low-density lipoprotein receptor-1

Biochemical and Biophysical Research Communications

Volumn 272, Issue 2, 2000, Pages 357-361

  Minami, Manabu ^a   Kume, Noriaki ^a   Kataoka, Hiroharu ^a   Morimoto, Masafumi ^a   Hayashida, Kazutaka ^a   Sawamura, Tatsuya ^b   Masaki, Tomoh ^b   Kita, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atherosclerosis; LOX 1; Oxidized low density lipoprotein; TGF 1; Vascular remodeling

Indexed keywords

CELL SURFACE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CATTLE; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; BOVINAE; EUKARYOTA; MURINAE;

EID: 0034616679     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2778     Document Type: Article

References (40)

1. Ross R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:1987;5928-5931.
3. Yla-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
4. Kume N., Cybulsky M. I., Gimbrone M. A. Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1992;1138-1144.
5. Kume N., Gimbrone M. A. Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93:1994;907-911.
6. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
7. Rohrer L., Freeman M., Kodama T., Penman M., Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343:1990;570-572.
8. Stanton L. W., White R. T., Bryant C. M., Protter A. A., Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267:1992;22446-22451.
9. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268:1993;4569-4572.
10. Endemann G., Stanton L. W., Madden K. S., Bryant C. M., White R. T., Protter A. A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:1993;11811-11816.
11. Acton S. L., Scherer P. E., Lodish H. F., Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269:1994;21003-21009.
12. Ramprasad M. P., Fischer W., Witztum J. L., Sambrano G. R., Quehenberger O., Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA. 92:1995;9580-9584.
13. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386:1997;73-77.
14. Moriwaki H., Kume N., Sawamura T., Aoyama T., Hoshikawa H., Ochi H., Nishi E., Masaki T., Kita T. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 18:1998;1541-1547.
15. Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc. Natl. Acad. Sci. USA. 95:1998;9535-9540.
16. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. 334:1998;9-13.
17. Moriwaki H., Kume N., Kataoka H., Murase T., Nishi E., Sawamura T., Masaki T., Kita T. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: Upregulated expression by TNF-alpha. FEBS Lett. 440:1998;29-32.
18. Draude G., Hrboticky N., Lorenz R. L. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem. Pharmacol. 57:1999;383-386.
19. Aoyama T., Chen M., Fujiwara H., Masaki T., Sawamura T. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett. 467:2000;217-220.
20. Kume N., Murase T., Moriwaki H., Aoyama T., Sawamura T., Masaki T., Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ. Res. 83:1998;322-327.
21. Murase T., Kume N., Korenaga R., Ando J., Sawamura T., Masaki T., Kita T. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ. Res. 83:1998;328-333.
22. Li D. Y., Zhang Y. C., Philips M. I., Sawamura T., Mehta J. L. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ. Res. 84:1999;1043-1049.
23. Morawietz H., Rueckschloss U., Niemann B., Duerrschmidt N., Galle J., Hakim K., Zerkowski H. R., Sawamura T., Holtz J. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation. 100:1999;899-902.
24. Kataoka H., Kume N., Miyamoto S., Minami M., Moriwaki H., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 99:1999;3110-3117.
25. Sporn M. B., Roberts A. B. Transforming growth factor-beta: Recent progress and new challenges. J. Cell Biol. 119:1992;1017-1021.
26. Border W. A., Ruoslahti E. Transforming growth factor-beta in disease: The dark side of tissue repair. J. Clin. Invest. 90:1992;1-7.
27. Schulick A. H., Taylor A. J., Zuo W., Qiu C. B., Dong G., Woodward R. N., Agah R., Roberts A. B., Virmani R., Dichek D. A. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Natl. Acad. Sci. USA. 95:1998;6983-6988.
28. Pollman M. J., Naumovski L., Gibbons G. H. Vascular cell apoptosis: Cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation. 99:1999;2019-2026.
29. Nikol S., Isner J. M., Pickering J. G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1992;1582-1592.
30. Kim S., Kawamura M., Wanibuchi H., Ohta K., Hamaguchi A., Omura T., Yukimura T., Miura K., Iwao H. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation. 92:1995;88-95.
31. Park I. S., Kiyomoto H., Abboud S. L., Abboud H. E. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 46:1997;473-480.
32. Bottalico L. A., Wager R. E., Agellon L. B., Assoian R. K., Tabas I. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266:1991;22866-22871.
33. Han J., Hajjar D. P., Tauras J. M., Feng J., Gotto A. M. Jr., Nicholson A. C. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 275:2000;1241-1246.
34. Roberts A. B., Flanders K. C., Kondaiah P., Thompson N. L., Van Obberghen-Schilling E., Wakefield L., Rossi P., de Crombrugghe B., Heine U., Sporn M. B. Transforming growth factor beta: Biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Rec. Prog. Horm. Res. 44:1988;157-197.
35. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:1990;597-641.
36. Assoian R. K., Komoriya A., Meyers C. A., Miller D. M., Sporn M. B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258:1983;7155-7160.
37. van Lenten B. J., Fogelman A. M. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J. Immunol. 148:1992;112-116.
38. Hsu H. Y., Nicholson A. C., Hajjar D. P. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J. Biol. Chem. 271:1996;7767-7773.
39. Zhang Y., Feng X. H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature. 394:1998;909-913.
40. Aoyama T., Sawamura T., Furutani Y., Matsuoka R., Yoshida M. C., Fujiwara H., Masaki T. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem. J. 339:1999;177-184.